The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Abroad (travel likely)RecruitingPHASE3

Conditions

Uveitis · Uveitis, Posterior · Uveitis, Anterior · Uveitis, Intermediate

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Texas Retina Associates, Plano, Texas, United States
Contact: Study coordinator (Jodi Creighton, COA) · jcreighton@texasretina.com · 214-692-6941
Contact: Study coordinator (Ann Mungioli) · amungioli@texasretina.com · 214-692-6941
Robert Wang, MD (Sub-investigator)
Contact: Principal Investigator (Rene Choi, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

Uveitis · YUTIQ

Abroad (travel likely)Recruiting

Tianjin, China

A Study of Uveitis in Children <18 Years of Age

Uveitis

Abroad (travel likely)Recruiting

Boston, United States · Akron, United States

RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age

Uveitis

Abroad (travel likely)Recruiting

Kansas City, United States · Boston, United States

Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography

Uveitis

Abroad (travel likely)Recruiting

Cleveland, United States